Cart
Free Shipping in Australia
Proud to be B-Corp

mRNA Therapeutics Sarfaraz K. Niazi (Therapeutic Proteins International, LLC, Chicago, Illinois, USA)

mRNA Therapeutics By Sarfaraz K. Niazi (Therapeutic Proteins International, LLC, Chicago, Illinois, USA)

Summary

The paradigm shift during the pandemic now allows us to develop new biologics that were never possible before and find treatments for autoimmune disorders that remain untreatable.

mRNA Therapeutics Summary

mRNA Therapeutics: Fast-to-Market Strategies by Sarfaraz K. Niazi (Therapeutic Proteins International, LLC, Chicago, Illinois, USA)

  • Unique and timely volume as mRNA is a hot area of research making great strides.
  • Covers the full-scale production systems that are needed to develop vaccines as well as elements of data needed to secure the IND approvals.
  • Introduces a commercial-scale manufacturing process using novel techniques like the PCR, in addition to the traditional plasmid DNA.
  • First book that offers commercial technology for developing and large-scale supply of mRNA products.
  • Renowned author and entrepreneur in the field of drug discovery and production.

About Sarfaraz K. Niazi (Therapeutic Proteins International, LLC, Chicago, Illinois, USA)

Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and the University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals, and treatment of autoimmune diseases. He has hands-on experience establishing biotechnology projects, from concept to market, including FDA approvals. In addition, he has first-hand experience in establishing RNA therapeutic product development and manufacturing, including the mRNA vaccine for COVID-19. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, and many heads of state. He is also a patent law practitioner. Email: [email protected]

Table of Contents

Background. 1. The Genome Machine. 2. Understanding Nucleic Acids. 3. RNA Therapeutics. 4. Nucleoside Vaccines. 5. cGMP mRNA Vaccine Manufacturing. 6. Regulatory Guidance. Appendix 1. Covid-19 mRNA Vaccine Manufacturing Feasibility. Appendix 2. Pharmacopeial Testing. Appendix 3. Suggested Readings

Additional information

NPB9781032163444
9781032163444
1032163445
mRNA Therapeutics: Fast-to-Market Strategies by Sarfaraz K. Niazi (Therapeutic Proteins International, LLC, Chicago, Illinois, USA)
New
Hardback
Taylor & Francis Ltd
2022-12-06
304
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - mRNA Therapeutics